» Articles » PMID: 34315640

Eliminating Cervical Cancer: Progress and Challenges for High-income Countries

Overview
Specialty Oncology
Date 2021 Jul 28
PMID 34315640
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

In 2020, the World Health Organization launched a major initiative to eliminate cervical cancer globally. The initiative is built around the three key pillars of human papillomavirus (HPV) vaccination, cervical screening and treatment, with associated intervention targets for the year 2030. The '90-70-90' targets specify that 90% of adolescent girls receive prophylactic HPV vaccination, 70% of adult women receive a minimum twice-in-a-lifetime cervical HPV test and 90% receive appropriate treatment for preinvasive or invasive disease. Modelling has shown that if these targets are met, the elimination of cervical cancer, defined as fewer than four cases per 100 000 women per annum, will be achieved within a century. Many high-income countries are well positioned to eliminate cervical cancer within the coming decades, but few have achieved '90-70-90' and many challenges must still be addressed to deliver these critical interventions effectively. This review considers the current status of cervical cancer control in relation to each of the three elimination pillars in high-income countries and discusses some of the developments that will assist countries in reaching these ambitious targets by 2030.

Citing Articles

High-Risk HPV Screening Initiative in Kosovo-A Way to Optimize HPV Vaccination for Cervical Cancer.

Bentz J, Barney R, Georgantzoglou N, Manxhuka-Kerliu S, Ibishi V, Dacaj-Elshani B Diseases. 2024; 12(8).

PMID: 39195188 PMC: 11353793. DOI: 10.3390/diseases12080189.


Findings and Challenges in Replacing Traditional Uterine Cervical Cancer Diagnosis with Molecular Tools in Private Gynecological Practice in Mexico.

Castrillo-Diez J, Rivera-Santiago C, Avila-Flores S, Barrera-Barrera S, Barrera-Saldana H Viruses. 2024; 16(6).

PMID: 38932179 PMC: 11209306. DOI: 10.3390/v16060887.


Artificial Intelligence and Colposcopy: Automatic Identification of Cervical Squamous Cell Carcinoma Precursors.

Mascarenhas M, Alencoao I, Carinhas M, Martins M, Cardoso P, Mendes F J Clin Med. 2024; 13(10).

PMID: 38792544 PMC: 11122610. DOI: 10.3390/jcm13103003.


Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort Study.

Gottschlich A, Hong Q, Gondara L, Alam M, Cook D, Martin R Cancer Epidemiol Biomarkers Prev. 2024; 33(7):904-911.

PMID: 38773687 PMC: 11216858. DOI: 10.1158/1055-9965.EPI-23-1587.


Novel ensemble learning approach with SVM-imputed ADASYN features for enhanced cervical cancer prediction.

Munshi R PLoS One. 2024; 19(1):e0296107.

PMID: 38198475 PMC: 10781159. DOI: 10.1371/journal.pone.0296107.